Approval · Notice of Compliance 25569 · 2021
ZENHALE: Notice of Compliance 25569
Issued March 30, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 25569
- Date
- March 30, 2021
- Company
- Organon Canada Inc.Kirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Change in produict ownership
Products in this notice
Medicinal ingredients
- MOMETASONE FUROATE 50 MCG per ACT
- FORMOTEROL FUMARATE DIHYDRATE 5 MCG per ACT
- MOMETASONE FUROATE 100 MCG per ACT
- MOMETASONE FUROATE 200 MCG per ACT